Literature DB >> 28478503

Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.

Yasuteru Inoue1, Mitsuharu Ueda2, Masayoshi Tasaki1, Akari Takeshima3, Akihito Nagatoshi1, Teruaki Masuda1, Yohei Misumi1, Takayuki Kosaka1, Toshiya Nomura1, Mayumi Mizukami1, Sayaka Matsumoto1, Taro Yamashita1, Hitoshi Takahashi3, Akiyoshi Kakita3, Yukio Ando1.   

Abstract

Sporadic cerebral amyloid angiopathy (CAA) is characterized by cerebrovascular amyloid beta (Aβ) deposits and causes cerebral hemorrhage and dementia. The exact molecules that co-accumulate with cerebrovascular Aβ deposits are still not fully known. In our study here, we performed proteomic analyses with microdissected leptomeningeal arteries and cerebral neocortical arterioles from 8 cases with severe CAA, 12 cases with mild CAA, and 10 control cases without CAA, and we determined the levels of highly expressed proteins in cerebral blood vessels in CAA. We focused on sushi repeat-containing protein 1 (SRPX1), which is specifically expressed in CAA-affected cerebral blood vessels. Because SRPX1, which is known as a tumor suppressor gene, reportedly induced apoptosis in tumor cells, we hypothesized that SRPX1 may play an important role in Aβ-induced apoptosis in CAA. Immunohistochemical studies revealed that SRPX1 co-accumulated with Aβ deposits in cerebral blood vessels of all autopsied cases with severe CAA. In contrast, no SRPX1 co-accumulated with Aβ deposits in senile plaques. Furthermore, we demonstrated that both Aβ40 and Aβ42 bound to SRPX1 in vitro and enhanced SRPX1 expression in primary cultures of cerebrovascular smooth muscle cells. SRPX1 enhanced caspase activity induced by Aβ40. Knockdown of SRPX1, in contrast, reduced the formation of Aβ40 accumulations and the activity of caspase in cultured cerebrovascular smooth muscle cells. SRPX1 may thus be a novel molecule that is up-regulated in cerebrovascular Aβ deposits and that may increase Aβ-induced cerebrovascular degeneration in CAA.

Entities:  

Keywords:  Amyloid β; Cerebral amyloid angiopathy; Cerebrovascular degeneration; Cytotoxicity; Proteomics; Sushi repeat-containing protein 1

Mesh:

Substances:

Year:  2017        PMID: 28478503     DOI: 10.1007/s00401-017-1720-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

1.  α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation.

Authors:  Yasuteru Inoue; Masayoshi Tasaki; Teruaki Masuda; Yohei Misumi; Toshiya Nomura; Yukio Ando; Mitsuharu Ueda
Journal:  Cell Mol Life Sci       Date:  2022-08-02       Impact factor: 9.207

Review 2.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

3.  Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.

Authors:  David C Hondius; Kristel N Eigenhuis; Tjado H J Morrema; Roel C van der Schors; Pim van Nierop; Marianna Bugiani; Ka Wan Li; Jeroen J M Hoozemans; August B Smit; Annemieke J M Rozemuller
Journal:  Acta Neuropathol Commun       Date:  2018-06-04       Impact factor: 7.801

4.  Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.

Authors:  Yoshinori Endo; Kazuhiro Hasegawa; Ryo Nomura; Hidetaka Arishima; Ken-Ichiro Kikuta; Taro Yamashita; Yasuteru Inoue; Mitsuharu Ueda; Yukio Ando; Mark R Wilson; Tadanori Hamano; Yasunari Nakamoto; Hironobu Naiki
Journal:  Acta Neuropathol Commun       Date:  2019-01-28       Impact factor: 7.801

Review 5.  Overlapping Protein Accumulation Profiles of CADASIL and CAA: Is There a Common Mechanism Driving Cerebral Small-Vessel Disease?

Authors:  Kelly Z Young; Gang Xu; Simon G Keep; Jimo Borjigin; Michael M Wang
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 4.307

6.  The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis.

Authors:  Eleanor Drummond; Thomas Wisniewski
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

7.  Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.

Authors:  Bryant Lim; Magda Tsolaki; Ihor Batruch; Anna Anastasiou; Antonis Frontistis; Ioannis Prassas; Eleftherios P Diamandis
Journal:  F1000Res       Date:  2019-11-11

Review 8.  Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.

Authors:  K W Li; Andrea B Ganz; August B Smit
Journal:  J Neurochem       Date:  2018-11-22       Impact factor: 5.372

Review 9.  Proteostasis in Cerebral Small Vessel Disease.

Authors:  Christof Haffner
Journal:  Front Neurosci       Date:  2019-11-15       Impact factor: 4.677

Review 10.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.